Wendy Stock to Myeloid Progenitor Cells
This is a "connection" page, showing publications Wendy Stock has written about Myeloid Progenitor Cells.
Connection Strength
0.177
-
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. J Clin Oncol. 2021 10 10; 39(29):3261-3272.
Score: 0.177